NASDAQ:CGNX - Cognex Stock Price, Price Target & More

Cognex trades on the NASDAQ under the ticker symbol "CGNX."

Cognex declared a quarterly dividend on Monday, April 30th. Investors of record on Friday, May 18th will be given a dividend of $0.045 per share on Friday, June 1st. This represents a $0.18 annualized dividend and a yield of 0.39%. The ex-dividend date is Thursday, May 17th. View Cognex's Dividend History.

Shares of Cognex split before market open on Monday, December 4th 2017. The 2-1 split was announced on Monday, October 30th 2017. The newly issued shares were distributed to shareholders after the closing bell on Friday, December 1st 2017. An investor that had 100 shares of Cognex stock prior to the split would have 200 shares after the split.

Cognex announced that its Board of Directors has authorized a share repurchase plan on Friday, February 16th 2018, which permits the company to repurchase $150,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to purchase shares of its stock through open market purchases. Shares repurchase plans are generally a sign that the company's management believes its stock is undervalued.

Cognex Co. (NASDAQ:CGNX) released its earnings results on Thursday, February, 15th. The scientific and technical instruments company reported $0.30 EPS for the quarter, beating analysts' consensus estimates of $0.25 by $0.05. The scientific and technical instruments company earned $180.37 million during the quarter, compared to analyst estimates of $178.75 million. Cognex had a net margin of 21.56% and a return on equity of 23.08%. The business's revenue for the quarter was up 39.5% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.20 EPS. View Cognex's Earnings History.

Cognex is scheduled to release their next quarterly earnings announcement on Monday, July, 30th 2018. View Earnings Estimates for Cognex.

9 Wall Street analysts have issued 12 month price targets for Cognex's stock. Their forecasts range from $40.00 to $80.00. On average, they expect Cognex's stock price to reach $57.4167 in the next twelve months. View Analyst Ratings for Cognex.

Cognex saw a increase in short interest during the month of April. As of April 13th, there was short interest totalling 9,239,250 shares, an increase of 26.7% from the March 30th total of 7,294,899 shares. Based on an average trading volume of 2,263,111 shares, the days-to-cover ratio is currently 4.1 days. Currently, 5.6% of the shares of the company are short sold.

Some companies that are related to Cognex include Roper Technologies (ROP), Fortive (FTV), Keysight (KEYS), Sensata Technologies (ST), MKS Instruments (MKSI), Orbotech (ORBK), Esterline (ESL), Rudolph Technologies (RTEC), Mesa Laboratories (MLAB), Hurco Companies (HURC), Universal Detection Technology (UNDT), Clearsign Combustion (CLIR), International Isotopes (INIS), Sypris Solutions (SYPR) and Elbit Vision Systems (EVSNF).

Media stories about CGNX stock have trended somewhat positive recently, according to Accern. The research firm identifies negative and positive press coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Cognex earned a media sentiment score of 0.03 on Accern's scale. They also gave news articles about the scientific and technical instruments company an impact score of 46.77 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the near future.

Cognex's stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (9.66%), Neuberger Berman Group LLC (2.01%), Franklin Resources Inc. (1.52%), OppenheimerFunds Inc. (1.46%), Eagle Asset Management Inc. (1.37%) and Bamco Inc. NY (1.07%). Company insiders that own Cognex stock include Anthony Sun, Bruce Robinson J, Jeffrey Benjamin Miller, Jerry A Schneider, John J Curran, Patrick Alias, Reuben Wasserman, Richard Morin, Robert Willett and Theodor Krantz. View Institutional Ownership Trends for Cognex.

CGNX stock was sold by a variety of institutional investors in the last quarter, including Barclays PLC, Carillon Tower Advisers Inc., Eagle Asset Management Inc., Prudential Financial Inc., OppenheimerFunds Inc., Artisan Partners Limited Partnership, Federated Investors Inc. PA and Millennium Management LLC. Company insiders that have sold Cognex company stock in the last year include Anthony Sun, Bruce Robinson J, Jeffrey Benjamin Miller, Jerry A Schneider, John J Curran, Patrick Alias, Robert Willett and Theodor Krantz. View Insider Buying and Selling for Cognex.

CGNX stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Old Mutual Global Investors UK Ltd., Franklin Resources Inc., Ownership Capital B.V., Legal & General Group Plc, Baird Financial Group Inc., Allianz Asset Management GmbH and Allianz Asset Management GmbH. View Insider Buying and Selling for Cognex.

Shares of CGNX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of CGNX stock can currently be purchased for approximately $46.71.

Cognex has a market capitalization of $8.06 billion and generates $747.95 million in revenue each year. The scientific and technical instruments company earns $177.17 million in net income (profit) each year or $1.45 on an earnings per share basis. Cognex employs 1,771 workers across the globe.

Cognex's mailing address is ONE VISION DRIVE, NATICK MA, 01760. The scientific and technical instruments company can be reached via phone at 508-650-3000 or via email at [email protected]